Oral contraceptive
Oral contraceptive is a pharmaceutical drug with 18 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
8 of 10 finished
20.0%
2 ended early
2
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
Clinical Trials (18)
A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives
Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.
A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects
A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products
A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
Oral Contraceptive DDI Study
Oral Contraceptives and Economic Behaviour
Medical Treatment of Endometriosis-Associated Pelvic Pain
Oral Contraceptive During Menopausal Transition
PCOS, Therapy and Markers of Cardiovascular Risk
A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers
Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
PED/PEA-15 Protein, PCOS, Obesity, Insulin Sensitivity Indexes, Metformin, Oral Contraceptives
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18